176 related articles for article (PubMed ID: 22150106)
1. Docking and QSAR comparative studies of polycyclic aromatic hydrocarbons and other procarcinogen interactions with cytochromes P450 1A1 and 1B1.
Gonzalez J; Marchand-Geneste N; Giraudel JL; Shimada T
SAR QSAR Environ Res; 2012 Jan; 23(1-2):87-109. PubMed ID: 22150106
[TBL] [Abstract][Full Text] [Related]
2. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
5. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
Jerabek P; Martinek V; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.
Shimada T; Fujii-Kuriyama Y
Cancer Sci; 2004 Jan; 95(1):1-6. PubMed ID: 14720319
[TBL] [Abstract][Full Text] [Related]
7. Comparative metabolism of the aza polynuclear aromatic hydrocarbon dibenz[a,h]acridine by recombinant human and rat cytochrome P450s.
Yuan ZX; Kumar S; Sikka HC
Chem Res Toxicol; 2004 May; 17(5):672-8. PubMed ID: 15144224
[TBL] [Abstract][Full Text] [Related]
8. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
[TBL] [Abstract][Full Text] [Related]
9. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
[TBL] [Abstract][Full Text] [Related]
11. Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1.
Yamazaki H; Hatanaka N; Kizu R; Hayakawa K; Shimada N; Guengerich FP; Nakajima M; Yokoi T
Mutat Res; 2000 Dec; 472(1-2):129-38. PubMed ID: 11113705
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.
Shimada T; Murayama N; Yamazaki H; Tanaka K; Takenaka S; Komori M; Kim D; Guengerich FP
Chem Res Toxicol; 2013 Apr; 26(4):529-37. PubMed ID: 23432465
[TBL] [Abstract][Full Text] [Related]
13. Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity.
Shimada T; Murajama N; Tanaka K; Takenaka S; Imai Y; Hopkins NE; Foroozesh MK; Alworth WL; Yamazaki H; Guengerich FP; Komori M
Chem Res Toxicol; 2008 Dec; 21(12):2313-23. PubMed ID: 19548353
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.
Shimada T; Yamazaki H; Foroozesh M; Hopkins NE; Alworth WL; Guengerich FP
Chem Res Toxicol; 1998 Sep; 11(9):1048-56. PubMed ID: 9760279
[TBL] [Abstract][Full Text] [Related]
15. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1.
Katiyar SK; Matsui MS; Mukhtar H
J Invest Dermatol; 2000 Feb; 114(2):328-33. PubMed ID: 10651994
[TBL] [Abstract][Full Text] [Related]
16. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo.
Kondraganti SR; Fernandez-Salguero P; Gonzalez FJ; Ramos KS; Jiang W; Moorthy B
Int J Cancer; 2003 Jan; 103(1):5-11. PubMed ID: 12455047
[TBL] [Abstract][Full Text] [Related]
17. Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1.
Milichovský J; Bárta F; Schmeiser HH; Arlt VM; Frei E; Stiborová M; Martínek V
Int J Mol Sci; 2016 Feb; 17(2):213. PubMed ID: 26861298
[TBL] [Abstract][Full Text] [Related]
18. Noncovalent interactions between hydroxylated polycyclic aromatic hydrocarbon and DNA: molecular docking and QSAR study.
Li F; Li X; Liu X; Zhang L; You L; Zhao J; Wu H
Environ Toxicol Pharmacol; 2011 Nov; 32(3):373-81. PubMed ID: 22004956
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human P450 forms 1A1, 1A2, and 1B1 catalyze the bioactivation of heterocyclic amine mutagens in Escherichia coli lacZ strains.
Josephy PD; Batty SM; Boverhof DR
Environ Mol Mutagen; 2001; 38(1):12-8. PubMed ID: 11473383
[TBL] [Abstract][Full Text] [Related]
20. Urban dust particulate matter alters PAH-induced carcinogenesis by inhibition of CYP1A1 and CYP1B1.
Courter LA; Musafia-Jeknic T; Fischer K; Bildfell R; Giovanini J; Pereira C; Baird WM
Toxicol Sci; 2007 Jan; 95(1):63-73. PubMed ID: 17060372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
